Lactobacillus brevis CD2
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Lactobacillus brevis CD2, covering 2014-03-13 to 2014-05-20. Get the full timeline:
Most recent: Clinical Trial Update: Effect of Lactobacillus Brevis CD2 in Prevention of Radio-chemotherapy Induced Oral Mucositis in Head and Neck Cancer [Phase 4]